Acryl Pushes Ahead with 'AI Hospital' Implementation, Targets Medical AX Market
Predicted impact: Low
AI hospital expansion to 17 hospitals; no contract value given, small relative to revenue.
Acryl아크릴
0007C0 · KOSDAQ · ₩0007C0 · 아크릴
₩14,800▲ ₩500 (3.50%)End-of-day · Oct 27, 2026 · End-of-day prices.
Price · 1Y −77.91%
- Market cap
- ₩119B
- Enterprise value
- ₩85B
- P/E
- —
- P/B
- 2.8×
- Dividend yield
- 0.0%
- ROE
- −6.7%
- Net margin
- −21.1%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−80.8% from the high
₩11,500Today: ₩14,320 – ₩14,950₩77,000
Returns
- 1W+3.6%
- 1M−22.3%
- 3M+7.7%
- 6M−63.0%
- YTD−60.2%
- 1Y—
- Volume today
- 60,508
- 0.4× the 20-day average
- Traded today
- ₩889M
- Listed shares
- 8,030,324
- EPS (12 months)
- −₩350
- Earnings yield −2.4%
AI research · InitiationAcryl: Loss-Making Newly Listed Software Firm Sees Sharp Share Price Drop Amid New Partnership NewsThe evidence is mixed.Read the full report →IPOListed Dec 16, 2025 at ₩19,500IPO details →
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 37 of 100 (50 is a normal day for this stock).
- SentimentPositiveNews: Upbeat reports of expansion to 17 hospitals and new market targeting. Community: 0 bullish, 0 bearish posts this week.
- MomentumWeak-28.3% over the last month; the price is below its 20-day average.
- News impactLow8 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Acryl stock overview
Acryl (아크릴, KRX: 0007C0) is listed on KOSDAQ, in the Software sector. Acryl is a Korean AI infrastructure company that supports the full AI development process, from infrastructure technology to service building, across industries. Its shares closed at ₩14,800 on Oct 27, 2026, up 3.50% on the day, giving it a market value of ₩119B.
Key facts
- Market cap
- ₩119B
- Sector
- Software
- Latest price change
- +3.50%
- As of
- Oct 27, 2026
- Main business
- Acryl is a Korean AI infrastructure company that supports the full AI development process, from infrastructure technology to service building, across industries.
Quick answers about Acryl
- What does Acryl do?
- Acryl is a Korean AI infrastructure company that supports the full AI development process, from infrastructure technology to service building, across industries. Its main products include the JONATHAN integrated AI platform, which comprises GPUBase, ModelBase and AgentBase, and the NADIA medical-specialized AI platform, with its next-generation intelligent hospital information system (Core) and AI-based digital medical devices (ESTHER). The company serves customers in healthcare, public sector, pharmaceuticals and bio, and F&B, and it is developing medical AI solutions under Korean government-led projects.
- What is the market cap of Acryl?
- The market capitalisation of Acryl was ₩119B at the close on Oct 27, 2026.
- Who are the largest shareholders of Acryl?
- According to the latest official filings, the largest reported holders are Park Oe-jin (25.38%, as of Jul 27, 2026); LG Electronics (7.96%, as of Jan 30, 2026); Nam Sang-yoon (7.96%, as of Dec 23, 2025).
- When is the next earnings report from Acryl?
- Korean companies rarely announce results dates in advance. Based on when Acryl filed the same report in past years, its next annual results is expected around Mar 18, 2027.
Company profile
Acryl is a Korean AI infrastructure company that supports the full AI development process, from infrastructure technology to service building, across industries. Its main products include the JONATHAN integrated AI platform, which comprises GPUBase, ModelBase and AgentBase, and the NADIA medical-specialized AI platform, with its next-generation intelligent hospital information system (Core) and AI-based digital medical devices (ESTHER). The company serves customers in healthcare, public sector, pharmaceuticals and bio, and F&B, and it is developing medical AI solutions under Korean government-led projects.
Written by AI from the company's latest annual report.
- Korean name
- 아크릴
- Sector
- Software
- CEO
- 박외진
- Founded
- Mar 2011
- Listed
- Dec 2025
- Listed shares
- 8,030,324
- Fiscal year ends
- Month 12
- Website
- www.acryl.ai/
Similar companies
- Hyundai Autoever307950 · ₩8.9T₩325,500+4.16%
- Krafton259960 · ₩8.4T₩182,500−0.54%
- NC036570 · ₩4.3T₩198,700−1.39%
- Netmarble251270 · ₩2.8T₩33,650+0.30%
- PearlAbyss263750 · ₩2.1T₩34,050−0.87%
- Shift UP462870 · ₩1.7T₩29,550+0.34%
- NHN181710 · ₩1.6T₩49,850+1.53%
- Kakao Games293490 · ₩1.3T₩11,850+5.80%
Recent news
Acryl moves forward in building 'AI hospital' with in-house medical AI model, expanding supply base to 17 hospitals nationwide
Predicted impact: Low
Expansion to 17 hospitals; incremental to the KT medical AI news already reported, no size disclosed.
Acryl advances 'AI hospital' implementation in line with government's 'AI basic medicine' strategy
Predicted impact: Low
AI hospital rollout with KT partnership; already widely reported in last 14 days with no size disclosed.
Recent filings
See all- Half-year report (Jun 2026)Aug 14, 2026
- Major sales or supply contractJul 28, 2026
- Insider shareholding reportJul 27, 2026
- 5%+ holding reportJul 27, 2026
- Major sales or supply contractJul 22, 2026
Titles in Korean until English translations are added.
Also known as: Acryl / 아크릴 / 0007C0 / KRX:0007C0
Source: KRX statistical information